Procurement Summary
Country: Belgium
Summary: Proton Therapy Indications
Deadline: 09 Apr 2026
Posting Date: 20 Mar 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 138149620
Document Ref. No.: 2024-08 (HTA) Proton therapy indications_pub01
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
73000000 - Research and development services and related consultancy services
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
The KCE has already published three reports on proton therapy. Since the last report in 2019, the scientific evidence base has been further developed and the results of several new studies on various types of tumours, including the first randomised controlled trials (RCTs), have been published. These new data provide an opportunity to gain a better understanding of the clinical indications in which proton therapy can offer significant benefits. At the same time, the Belgian reimbursement framework has changed. These procedural changes, combined with the emergence of new clinical evidence, now make it necessary to reassess the current indications for proton therapy. Category (CPV code): Research and development services and related consultancy services (73000000)
General purpose: Competition Specific purpose: Contract or concession - standard regime Initially dispatched at: 19/03/2026 Last dispatched at: 19/03/2026
Documents
Tender Notice
notices_ccb3cf20-f0d8-4a19-a0b9-d85bc01fe7a2.zip